- Member Since: August 21, 2019
U.S. Food and Drug Administration (FDA) placed a Boxed Warning for enhanced risk of death with gout prescription drug Uloric (febuxostat)
conduct a large postmarket safety clinical trial. The trial was conducted in over 6,000 patients with gout treated with either Uloric or allopurinol. The primary result was a combination of heart-related death, non-deadly heart attack, non-deadly stroke, and a condition of insufficient blood supply to the heart requiring intervention, called unstable angina.
Does Your Issue Qualify for a Lawsuit Against the Makers of Uloric? According to the new Black Box warnings required by the FDA, use of Uloric can elevate the risk of experiencing one of the following conditions:
Pulmonary Embolism (PE)
Deep Vein Thrombosis (DVT)
If you or a loved one has suffered any of the above while using Uloric for the condition of gout, you may be entitled to a settlement from Takeda Pharmaceuticals, as well as for expenses, emotional distress, and inconveniences you have endured as a result of your medical treatment.
uloric stroke at The Meneo Law Group not only have the skill, experience, and knowledge to handle your Uloric lawsuit, but a proven history of success in representing people, like you, that have been injured by dangerous medications and products.